CA Patent

CA3257852A1 — Silicon-based fluoride acceptor groups for radiopharmaceuticals

Assigned to Technische Universitaet Muenchen · Expires 2024-02-01 · 2y expired

What this patent protects

The invention relates to novel silicon-based fluoride acceptor groups (SiFA groups) of the following formulae (Ia, Ib, Ic) as well as to compounds suitable for use in radiopharmacy comprising such groups, wherein R1 and R2 are each a linear or branched C3 to C10 alkyl group and R…

USPTO Abstract

The invention relates to novel silicon-based fluoride acceptor groups (SiFA groups) of the following formulae (Ia, Ib, Ic) as well as to compounds suitable for use in radiopharmacy comprising such groups, wherein R1 and R2 are each a linear or branched C3 to C10 alkyl group and R3 is selected from (i) -OH or -O-, (ii) a sugar moiety or an amino sugar moiety, (iii) an amino acid moiety or an oligopeptide moiety, (iv) a PEG moiety; and from combinations of two or more of (ii), (iii) and (iv).

Drugs covered by this patent

Patent Metadata

Patent number
CA3257852A1
Jurisdiction
CA
Classification
—
Expires
2024-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Technische Universitaet Muenchen
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.